Bristol-Myers Squibb and AstraZeneca have announced the results from a 24-week phase 3 clinical study, which demonstrated that dapagliflozin, added to metformin, showed significant mean reductions in the
Novartis has begun delivering the first batch of swine flu shots to the US, reported Expatica. “We have been delivering the first doses to the United States since
Sanofi Pasteur has announced an interim analysis of data from clinical trials of the US licensed Influenza A (H1N1) 2009 Monovalent Vaccine in adults 18 years through 64
Generic version of Tamiflu (Oseltamivir) will now be available in Indian market, after several months of swine flu attack. A week ago Natco Pharma and Strides Arcolabs have
Allergan has filed a declaratory relief action in the US District Court for the District of Columbia seeking a ruling that would allow Allergan to proactively share truthful
The Dow Chemical sells its interest in Morton International to K+S Aktiengesellschaft for $1.675 billion. The company said that approximately one billion dollars in proceeds from this transaction
SciClone Pharmaceuticals has discontinued the investigational treatments under its randomised, placebo-controlled, double-blind phase 2 trial evaluating RP101. RP101 is a nucleoside analog known as BvdU, intended for the
Amicus Therapeutics (Amicus) has reported preliminary results from its phase 2 randomised, open-label study to assess the safety, tolerability and preliminary efficacy of its investigational drug, Plicera (afegostat
Actavis has announced that its third-party sales division, Medis, has delivered 30 million tablets of Atorvastatin to its clients in Spain. The product, Atorvastatin Magnesium, is launched by
KINAXO Biotechnologies has added KinAffinity to its service portfolio. KinAffinity provides invaluable information about a kinase inhibitor’s selectivity in a cell or tissue of interest. It simultaneously determines
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.